1Assistant Professor, Dr. Vithalrao Vikhe Patil Foundation’s College of Nursing, Ahmednagar, Maharashtra, India
2Associate Professor, Dr. Vithalrao Vikhe Patil Foundation’s College of Nursing, Ahmednagar, Maharashtra, India
*Corresponding Author E-mail: Shivaleela.238@gmail.com
Online published on 8 June, 2021.
Leprosy is an infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. The disease mainly affects the skin, the peripheral nerves, mucosa of the upper respiratory tract, and the eyes. Leprosy is curable and treatment in the early stages can prevent disability.
Leprosy is curable with multidrug therapy (MDT).
Leprosy is likely transmitted via droplets, from the nose and mouth, during close and frequent contact with untreated cases.
Early Diagnosis And Treatment With Multidrug Therapy (MDT) Remain Key In Eliminating The Disease As A Public Health Concern.
Untreated, Leprosy Can Cause Progressive And Permanent Damage To The Skin, Nerves, Limbs And Eyes.
There Were 208 619 New Leprosy Cases Registered Globally In 2018, According To Official Figures from 159 Countries from The 6 WHO Regions.
Based On 184 212 Cases At The End Of 2018, Prevalence Rate Corresponds To 0.2/10 000.
Leprosy, Mycobacterium Leprae, Multidrug therapy, Communicable disease
